Developer docs
API playgroundTry for free, no card

Search company profiles

Olympian Clinical Research

Full company profile

uuid002f3wp

Namestring
Olympian Clinical Research
Legal namestring
Olympian Clinical Research
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Olympian Clinical Research is a privately held clinical research site founded in 2007 in Tampa, Florida by Dr. Panos Vasiloudes. It conducts Phase I–IV clinical trials (primarily Phase II and III) for both adult and pediatric patients across dermatological indications — atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, plaque psoriasis, alopecia areata, vitiligo — and non-dermatological indications including endometriosis, migraines, depression, Alzheimer's disease, schizophrenia, OCD, and fibromyalgia.

The company operates three physical office locations in the Tampa Bay area (Tampa headquarters, Clearwater, and Saint Petersburg) and is strategically affiliated with Academic Alliance in Dermatology, a 16-office dermatology practice group with 20 providers and a database of more than 150,000 patients that serves as the primary recruitment backbone for OCR's dermatology trials. Participant-facing services include free study-related care and medication, stipends for time and travel, and a Refer-a-Friend recruitment program; sponsor/CRO-facing services include protocol execution, data collection, and regulatory compliance under FDA-sponsored studies.

OCR generates revenue by performing clinical trial conduct services for pharmaceutical sponsors and Contract Research Organizations, receiving compensation for participant recruitment, study execution, and regulatory deliverables. Its go-to-market is community-led: patients are recruited through the affiliated AAD database, community outreach, referral programs, and an educational content-marketing blog, while sponsor relationships are pursued through direct outreach to CROs and pharma. The company is a MAGI Blue Ribbon Site Charter Member and remains founder-led, with no disclosed external institutional investment.

Short descriptiontext

Olympian Clinical Research is a Tampa-based clinical research site conducting Phase I-IV trials in dermatology and other therapeutic areas for pharma sponsors and CROs, leveraging affiliation with Academic Alliance in Dermatology's 150,000+ patient database.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTampa, United States
HQ citystring
Tampa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, dermatology research, Phase II trials, clinical study enrollment, medical research site
Industry2 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAKACAL
Psoriasis & Eczema Specialty Care
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Clinical Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Conduct Services
TypeProfessional Services
Description

Olympian Clinical Research generates revenue by conducting clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). They receive compensation for participant recruitment, study execution, data collection, and regulatory compliance. Study-related care and medications are provided at no cost to participants, with participants receiving stipends for time and travel.

olympianresearch.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Olympian Clinical Research is a clinical research site network that conducts Phase I–IV clinical trials for pharmaceutical and biotechnology sponsors, with specialization in Phase II and III dermatology studies (e.g., atopic dermatitis, psoriasis, hidradenitis suppurativa, chronic spontaneous urticaria, prurigo nodularis) and selected non-dermatology indications. The company recruits and retains study participants, performs protocol-driven assessments by board-certified specialists drawn from its affiliate Academic Alliance in Dermatology, and supplies sponsors and CROs with regulatory-grade clinical data across adult and pediatric populations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Olympian Clinical Research operates as a clinical research organization offering Phase I-IV clinical trials primarily in Phase II & III for both adult and pediatric patients. The company conducts FDA-sponsored clinical research studies across two main areas: dermatological conditions (including atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, plaque psoriasis, vitiligo, and alopecia areata) and non-dermatological conditions (including endometriosis, depression, migraines, Alzheimer's disease, and other systemic disorders). The organization provides study-related care, medication at no cost, and compensation for time and travel to eligible participants. Additional services include a patient referral program and pre-screening intake paperwork. Founded in 2007 and affiliated with Academic Alliance in Dermatology, the company has 16 offices across the Tampa area with access to over 150,000 patients.

Product and service5 records
1Phase I–IV Clinical Trial Site Services
CategoryClinical Research Services
Description

Site-based clinical trial execution for pharmaceutical and biotechnology sponsors across all clinical phases, with specialist depth in Phase II and III, including protocol-driven recruitment, consent, dosing visits, assessments, and regulatory-grade data collection for adult and pediatric participants.

2Dermatology Clinical Trials
CategoryClinical Research Services — Dermatology
Description

Site-based Phase I–IV dermatology clinical trials for indications including atopic dermatitis, chronic spontaneous urticaria, hidradenitis suppurativa, plaque psoriasis, prurigo nodularis, and acne, evaluating investigational therapies on behalf of pharmaceutical sponsors and CROs.

3Non-Dermatology Clinical Trials
CategoryClinical Research Services — Multi-Indication
Description

Site-based Phase I–IV clinical trials conducted outside the dermatology specialty, covering selected indications such as osteoarthritis, chronic kidney disease, and hyperlipoproteinemia, delivered for pharmaceutical sponsors using the same site infrastructure and recruitment database.

4Healthy Patient/Volunteer Studies
CategoryClinical Research Services — Healthy Volunteer
Description

Site-conducted clinical trials enrolling healthy adult and pediatric volunteers for pharmacokinetic, safety, and bioequivalence studies contracted by sponsors and CROs.

5Pediatric Clinical Trials
CategoryClinical Research Services — Pediatric
Description

Age-appropriate site-based clinical trial conduct for pediatric populations across qualifying dermatology and healthy-volunteer studies, including parental-consent workflows and pediatric-specific dosing assessments.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Olympian Clinical Research is affiliated with Academic Alliance in Dermatology, a dermatology practice group with 16 offices in the Tampa area, 20 providers, and a database of over 150,000 patients. This affiliation provides the primary patient recruitment channel and clinical infrastructure for conducting clinical trials.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dermatology-focused clinical research site network with multi-location enrollment for inflammatory skin disease trials. Comparable due to single-therapeutic focus on dermatology, parallel sponsor base, and similar Phase II/III protocol mix.

TypeDirect peer
Description

Hybrid decentralized clinical research site network combining dedicated research sites with community-based physician partnerships for patient recruitment. Comparable because both organizations leverage affiliated physician/clinical databases to enroll trial participants.

TypeBroad incumbent
Description

Established multi-site clinical research network (now part of a larger CRO platform) that operates dedicated research sites across the U.S. Comparable as a broader, better-capitalized incumbent offering sponsors the multi-region site coverage Olympian currently lacks.

TypeDirect peer
Description

Multi-specialty clinical research site network operating across several U.S. states with a Phase I–IV trial portfolio for sponsors. Closely comparable in business model (multi-site contract research services) and recruiting model (database-driven enrollment).

TypeBroad incumbent
Description

Large clinical research services and technology provider offering data, endpoint, and site-supporting services to pharmaceutical sponsors running trials. Comparable as a broader incumbent in clinical research services whose offerings intersect with the operational needs of PI-led sites.

6Meridien Research
TypeDirect peer
Description

Florida-based clinical research site network with multiple locations across the Tampa Bay and central Florida region, running Phase II–IV trials in dermatology and other specialties. Highly comparable given shared Florida geography and overlapping dermatology and chronic-condition trial mix.

TypeBroad incumbent
Description

Global CRO and clinical research services provider that owns and operates site networks in addition to its core CRO business. Relevant as both a customer of independent sites (sponsor/CRO counterparty) and as a competitor that could absorb regional sites into its integrated network.

8Research Across America
TypeDirect peer
Description

Independent multi-specialty clinical trial site group operating Phase II–IV studies across therapeutic areas including dermatology. Directly comparable as a similarly sized independent site network serving the same sponsor and CRO customer base.

TypeDirect peer
Description

Multi-site clinical research organization operating a network of dedicated research centers across the U.S. that conduct Phase I–IV trials for pharmaceutical sponsors and CROs, directly comparable to Olympian's model of multi-site Phase II/III trial conduct.

TypeEmerging player
Description

Multi-site clinical research organization built by consolidating independent research sites, running Phase I–IV trials across several U.S. regions. Comparable in operating model and as a likely competitive consolidator of independent sites like Olympian.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Olympian Clinical Research

Clinical Research Servicesolympianresearch.com

Olympian Clinical Research is a Tampa-based clinical research site conducting Phase I-IV trials in dermatology and other therapeutic areas for pharma sponsors and CROs, leveraging affiliation with Academic Alliance in Dermatology's 150,000+ patient database.

What Olympian Clinical Research does

Olympian Clinical Research is a privately held clinical research site founded in 2007 in Tampa, Florida by Dr. Panos Vasiloudes. It conducts Phase I–IV clinical trials (primarily Phase II and III) for both adult and pediatric patients across dermatological indications — atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, plaque psoriasis, alopecia areata, vitiligo — and non-dermatological indications including endometriosis, migraines, depression, Alzheimer's disease, schizophrenia, OCD, and fibromyalgia.

The company operates three physical office locations in the Tampa Bay area (Tampa headquarters, Clearwater, and Saint Petersburg) and is strategically affiliated with Academic Alliance in Dermatology, a 16-office dermatology practice group with 20 providers and a database of more than 150,000 patients that serves as the primary recruitment backbone for OCR's dermatology trials. Participant-facing services include free study-related care and medication, stipends for time and travel, and a Refer-a-Friend recruitment program; sponsor/CRO-facing services include protocol execution, data collection, and regulatory compliance under FDA-sponsored studies.

OCR generates revenue by performing clinical trial conduct services for pharmaceutical sponsors and Contract Research Organizations, receiving compensation for participant recruitment, study execution, and regulatory deliverables. Its go-to-market is community-led: patients are recruited through the affiliated AAD database, community outreach, referral programs, and an educational content-marketing blog, while sponsor relationships are pursued through direct outreach to CROs and pharma. The company is a MAGI Blue Ribbon Site Charter Member and remains founder-led, with no disclosed external institutional investment.

Olympian Clinical Research firmographics

Firmographics
Name
Olympian Clinical Research
Legal name
Olympian Clinical Research
Website
https://olympianresearch.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
Olympian Clinical Research is a Tampa-based clinical research site conducting Phase I-IV trials in dermatology and other therapeutic areas for pharma sponsors and CROs, leveraging affiliation with Academic Alliance in Dermatology's 150,000+ patient database.
Ownership category
akta.pro rank

Olympian Clinical Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAKACAL
Psoriasis & Eczema Specialty Care

Keywords

  • Clinical trial services
  • Dermatology research
  • Phase II trials
  • Clinical study enrollment
  • Medical research site

Where Olympian Clinical Research is headquartered

Location

Headquarters

HQ city
Tampa
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Olympian Clinical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Trial Conduct Services: Olympian Clinical Research generates revenue by conducting clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). They receive compensation for participant recruitment, study execution, data collection, and regulatory compliance. Study-related care and medications are provided at no cost to participants, with participants receiving stipends for time and travel.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Olympian Clinical Research product offering

Product offering

Core offering

Olympian Clinical Research is a clinical research site network that conducts Phase I–IV clinical trials for pharmaceutical and biotechnology sponsors, with specialization in Phase II and III dermatology studies (e.g., atopic dermatitis, psoriasis, hidradenitis suppurativa, chronic spontaneous urticaria, prurigo nodularis) and selected non-dermatology indications. The company recruits and retains study participants, performs protocol-driven assessments by board-certified specialists drawn from its affiliate Academic Alliance in Dermatology, and supplies sponsors and CROs with regulatory-grade clinical data across adult and pediatric populations.

Product overview

Olympian Clinical Research operates as a clinical research organization offering Phase I-IV clinical trials primarily in Phase II & III for both adult and pediatric patients. The company conducts FDA-sponsored clinical research studies across two main areas: dermatological conditions (including atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, plaque psoriasis, vitiligo, and alopecia areata) and non-dermatological conditions (including endometriosis, depression, migraines, Alzheimer's disease, and other systemic disorders). The organization provides study-related care, medication at no cost, and compensation for time and travel to eligible participants. Additional services include a patient referral program and pre-screening intake paperwork. Founded in 2007 and affiliated with Academic Alliance in Dermatology, the company has 16 offices across the Tampa area with access to over 150,000 patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phase I–IV Clinical Trial Site Services Site-based clinical trial execution for pharmaceutical and biotechnology sponsors across all clinical phases, with specialist depth in Phase II and III, including protocol-driven recruitment, consent, dosing visits, assessments, and regulatory-grade data collection for adult and pediatric participants.
  • Dermatology Clinical Trials Site-based Phase I–IV dermatology clinical trials for indications including atopic dermatitis, chronic spontaneous urticaria, hidradenitis suppurativa, plaque psoriasis, prurigo nodularis, and acne, evaluating investigational therapies on behalf of pharmaceutical sponsors and CROs.
  • Non-Dermatology Clinical Trials Site-based Phase I–IV clinical trials conducted outside the dermatology specialty, covering selected indications such as osteoarthritis, chronic kidney disease, and hyperlipoproteinemia, delivered for pharmaceutical sponsors using the same site infrastructure and recruitment database.
  • Healthy Patient/Volunteer Studies Site-conducted clinical trials enrolling healthy adult and pediatric volunteers for pharmacokinetic, safety, and bioequivalence studies contracted by sponsors and CROs.
  • Pediatric Clinical Trials Age-appropriate site-based clinical trial conduct for pediatric populations across qualifying dermatology and healthy-volunteer studies, including parental-consent workflows and pediatric-specific dosing assessments.

Companies that use Olympian Clinical Research

Customer profile

Segments2 records

Ideal customer profiles2 records

Olympian Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Olympian Clinical Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Academic Alliance in DermatologycoreStrategic or Co-development PartnerOlympian Clinical Research is affiliated with Academic Alliance in Dermatology, a dermatology practice group with 16 offices in the Tampa area, 20 providers, and a database of over 150,000 patients. This affiliation provides the primary patient recruitment channel and clinical infrastructure for conducting clinical trials.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Olympian Clinical Research competitors and assessment

Company assessment

Direct peers

  • Pinnacle Clinical Research: Dermatology-focused clinical research site network with multi-location enrollment for inflammatory skin disease trials. Comparable due to single-therapeutic focus on dermatology, parallel sponsor base, and similar Phase II/III protocol mix.
  • Elligo Health Research: Hybrid decentralized clinical research site network combining dedicated research sites with community-based physician partnerships for patient recruitment. Comparable because both organizations leverage affiliated physician/clinical databases to enroll trial participants.
  • Accel Research Sites: Multi-specialty clinical research site network operating across several U.S. states with a Phase I–IV trial portfolio for sponsors. Closely comparable in business model (multi-site contract research services) and recruiting model (database-driven enrollment).
  • Meridien Research: Florida-based clinical research site network with multiple locations across the Tampa Bay and central Florida region, running Phase II–IV trials in dermatology and other specialties. Highly comparable given shared Florida geography and overlapping dermatology and chronic-condition trial mix.
  • Research Across America: Independent multi-specialty clinical trial site group operating Phase II–IV studies across therapeutic areas including dermatology. Directly comparable as a similarly sized independent site network serving the same sponsor and CRO customer base.
  • Velocity Clinical Research: Multi-site clinical research organization operating a network of dedicated research centers across the U.S. that conduct Phase I–IV trials for pharmaceutical sponsors and CROs, directly comparable to Olympian's model of multi-site Phase II/III trial conduct.

Broad incumbents

  • PMG Research: Established multi-site clinical research network (now part of a larger CRO platform) that operates dedicated research sites across the U.S. Comparable as a broader, better-capitalized incumbent offering sponsors the multi-region site coverage Olympian currently lacks.
  • Clario: Large clinical research services and technology provider offering data, endpoint, and site-supporting services to pharmaceutical sponsors running trials. Comparable as a broader incumbent in clinical research services whose offerings intersect with the operational needs of PI-led sites.
  • IQVIA: Global CRO and clinical research services provider that owns and operates site networks in addition to its core CRO business. Relevant as both a customer of independent sites (sponsor/CRO counterparty) and as a competitor that could absorb regional sites into its integrated network.

Emerging players

  • Flourish Research: Multi-site clinical research organization built by consolidating independent research sites, running Phase I–IV trials across several U.S. regions. Comparable in operating model and as a likely competitive consolidator of independent sites like Olympian.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Olympian Clinical Research social profiles

Digital presence

Olympian Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Olympian Clinical Research leadership team

Management profile

Number of profiles

Profiles1 record

Olympian Clinical Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Olympian Clinical Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olympian Clinical Research

What does Olympian Clinical Research do?

Olympian Clinical Research is a clinical research site network that conducts Phase I–IV clinical trials for pharmaceutical and biotechnology sponsors, with specialization in Phase II and III dermatology studies (e.g., atopic dermatitis, psoriasis, hidradenitis suppurativa, chronic spontaneous urticaria, prurigo nodularis) and selected non-dermatology indications. The company recruits and retains study participants, performs protocol-driven assessments by board-certified specialists drawn from its affiliate Academic Alliance in Dermatology, and supplies sponsors and CROs with regulatory-grade clinical data across adult and pediatric populations.

Is Olympian Clinical Research a public or private company?

Olympian Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Olympian Clinical Research founded?

Olympian Clinical Research was founded in 2007. It employs 1 to 10 people.

Where is Olympian Clinical Research based?

Olympian Clinical Research is headquartered in Tampa, United States, in the North America region.

How does Olympian Clinical Research make money?

One revenue line is on record: clinical Trial Conduct Services.

Who are Olympian Clinical Research's main competitors?

Direct peers on record are Pinnacle Clinical Research, Elligo Health Research, Accel Research Sites, Meridien Research, Research Across America and Velocity Clinical Research. Broad incumbents are PMG Research, Clario and IQVIA. Flourish Research is listed as an emerging player.

Does Olympian Clinical Research have an API?

No public API is recorded for Olympian Clinical Research.

What industry is Olympian Clinical Research in?

Olympian Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAKACAL, Psoriasis & Eczema Specialty Care. Its NAICS code is 5417 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales